• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Arsenal Biosciences

reducing people on team
Biotech

ArsenalBio halves staff amid reorganization efforts

The shift to a clinical focus does not impact the Bay Area biotech’s long-standing collaboration with BMS, an ArsenalBio spokesperson said.
Darren Incorvaia Sep 17, 2025 4:55pm
biotechs top money raisers hero image

Biotech's top money raisers: 2024

Mar 3, 2025 5:00am
money private equity venture capital investment cash dollar sign investor

Arch closes $3B-plus fund to foster biopharma upstarts

Sep 26, 2024 10:24am
neighborhood suburb

ArsenalBio raises $325M, pivots away from former lead asset

Sep 4, 2024 8:00am
Graphic of someone identifying a candidate out of a crowd using a magnifying class

New Biogen research chief aims to add biotech hustle to pharma

Oct 10, 2023 10:50am
2022 money

Biotech's top money raisers: 2022

Apr 11, 2023 9:19am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings